Assessing Medical Preparedness for Extreme Heat at Marathons
A firsthand account of heat-related incidents at the NYC Marathon highlights the urgent need for better medical planning in response to climate change.
October 02, 2026
Sports
Sports event coverage and updates
New Medicare Drug Pricing Rule and Eli Lilly's Weight Loss Drug Show Promise
The Trump administration's latest Medicare drug pricing rule falls short, while Eli Lilly's combination therapy shows significant weight loss results.
October 01, 2026
Understanding the Rise of GLP-1 Prescriptions for Children with Obesity
A significant surge in GLP-1 prescriptions for children highlights a growing response to childhood obesity and its medical implications.
October 01, 2026
Can Eric Cantor Revitalize Pharma's Image Among Voters?
Eric Cantor seeks to reshape the pharmaceutical industry's image and policies to align with voter concerns, revisiting past strategies aimed at broader public appeal.
October 01, 2026
The Dire Future of Employer-Sponsored Health Insurance
The outlook for employer-sponsored health insurance is grim, with experts predicting even higher costs in 2027, as recent trends worsen the situation.
September 28, 2026
Uncovering New Insights in Cardiac Anatomy Through Observation
A recent discovery in the anatomy of the heart challenges established knowledge, revealing a previously unrecognized structure and its implications for stroke risk.
September 28, 2026
Trump Announces State Participation in Drug Price Reduction Initiative
President Trump's recent announcement highlights efforts to reduce Medicaid drug prices, but many details remain unclear.
September 18, 2026
Obesity Treatments Being Evaluated for Young Children
Drugmakers are investigating the use of obesity treatments in children as young as six, reflecting a shift in pediatric health approaches.
September 15, 2026
Reviving Joy in Vaccine Advocacy: A Call for Celebration and Engagement
To counteract vaccine hesitancy, the pro-vaccine movement must reignite enthusiasm and communal spirit, incorporating joy and engagement into advocacy.
September 11, 2026
Novartis' Pelacarsen Fails to Show Efficacy in Key Cardiovascular Trial
The Phase 3 trial for Novartis' cardiovascular drug pelacarsen concluded without significant results, impacting its potential in heart disease treatment.
September 04, 2026
Hope Remains for Angelman Syndrome Treatments Despite Recent Setback
While a drug for Angelman syndrome failed in trials, experts believe other experimental therapies may still hold promise for neurological conditions.
September 04, 2026
The Health Insurance Risks Faced by Disabled Workers Amid Medicaid Changes
A recent report highlights that disabled workers may face significant health insurance coverage losses as Medicaid work requirements are set to change.
September 04, 2026
Bristol Myers Squibb Halts CAR-T Trials Amid Safety Concerns
Bristol Myers Squibb has paused its CAR-T therapy trials for autoimmunity due to severe side effects, raising questions about transparency.
September 04, 2026
FDA Eases Clozapine Restrictions, Yet Physicians Remain Hesitant to Prescribe It for Children
The FDA's removal of clozapine's monitoring requirements is pivotal, but fear still hinders clinicians from prescribing it to young patients with schizophrenia.
September 04, 2026
Trump Administration Announces New Drug Pricing Pledges: Key Unanswered Questions
A new round of pharmaceutical price cuts has been announced, but crucial details and implications remain unclear.
September 01, 2026
Novartis Secures Milestone with BTK Inhibitor in Multiple Sclerosis Treatment
Novartis celebrates a significant milestone with its BTK inhibitor for multiple sclerosis, advancing the treatment landscape for the disease.
September 01, 2026
Novartis Drug Pacibekitug Shows Promise in Reducing Inflammation for Heart Disease
Novartis' latest drug, pacibekitug, successfully reduces inflammation in a Phase 2 study, suggesting potential for cardiovascular treatment.
August 29, 2026
Alnylam Eyes AstraZeneca and Ionis Heart Drug Setback as Industry Watches Closely
AstraZeneca and Ionis' heart disease treatment faced an unexpected failure, raising concerns and interest among biotech competitors like Alnylam.
August 28, 2026
Disputed Vaccine Theories Resurface in Federal Autism Committee Meeting
Members of a federal autism advisory committee controversially endorse vaccines as a cause of autism, despite overwhelming scientific refutation.
August 28, 2026
Rising Health Care Costs Challenge Large Employers
Recent findings highlight the surprising surge in health care costs for major companies, prompting scrutiny and reevaluation of existing healthcare strategies.
August 26, 2026